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Abstract 
Background 
Active warming reduces risk of surgical complications. Implementation of a perioperative thermal 
care bundle increased use of active warming for surgical patients. 
Objective 
This study aimed to determine if implementing a thermal care bundle to prevent inadvertent 
perioperative hypothermia is cost-effective.  
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Design 
A model-based cost-effectiveness analysis was undertaken using Monte Carlo simulations from input 
distributions to estimate costs and effects.  
Setting 
Hospitals undertaking between 5,000 and 40,000 surgeries per year, which either implemented or 
did not implement the thermal care bundle, were modelled. 
Participants 
The decision tree guiding the structure of the model was populated with clinical outcomes (surgical 
site infection, blood transfusion requirement and morbid cardiac events) of a hypothetical cohort of 
surgical patients.  
Interventions 
Implementation or non-implementation of the thermal care bundle. 
Main outcome measures 
Net monetary benefit was calculated by multiplying the health benefits (quality-adjusted life years) 
by the willingness-to-pay threshold minus the cost. We tested a range of values for willingness to 
pay per quality-adjusted life year thresholds and plotted results for expected incremental benefits 
and probability of cost-effectiveness. The incremental cost-effectiveness ratio was also calculated. 
Results 
Thermal care bundle implementation simultaneously reduced costs and increased quality-adjusted 
life years in the majority of simulations (88.1%). The average cost reduction was $689,659 (95% 
credible intervals spanned from a $2,718,364 decrease in costs to $379,826 increase in costs) and 
average difference in quality-adjusted life years was 54 (95% CI=0.4 less to 176 more). This equated 
to an incremental cost-effectiveness ratio of $12747 saved per quality-adjusted life year gained. 
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Conclusions 
It is likely that increasing use of active warming by implementing the thermal care bundle would 
generate cost-savings and improve the quality of life for surgical patients. It would be good value for 
hospitals with similar characteristics to those included in our model to allocate the extra resources 
required for implementation.   
 
Keywords: Hypothermia: prevention; OR costs: labour vs materials; nurses; nursing; temperature; 
active warming 
 
Introduction 
Forced air warming is recommended for surgery performed with general and regional anaesthesia 
because it has been shown to reduce the risk of surgical site infections (1) and cardiac events as well 
as decrease surgical bleeding.(2) A British cost-effectiveness study identified that the use of active 
warming dominated standard care for patients undergoing surgery.(2) Despite the high quality 
evidence supporting the clinical and cost-effectiveness of active warming, as well as clinical guideline 
recommendations calling for its use, results from studies that have examined its application in real-
world practice have revealed a considerable evidence-practice gap. For example, a multi-centre 
study in Australia identified that 45% of surgical patients did not receive active warming when 
indicated.(3) A Chinese study conducted across 28 hospitals revealed that active warming was rarely 
used, with less than 15% of a cohort of more than 3,000 surgical patients studied being warmed with 
electric heaters or blankets.(4) Moreover, in the largest observational study performed to date, 46% 
of all patients (n=50,689) admitted to an ICU after major elective surgery were hypothermic.(5) 
In response, we systematically developed and evaluated the Thermal Care Bundle and investigated 
whether it increased adherence to clinical guideline recommendations for the thermal care of 
patients undergoing surgery. Detailed descriptions of the bundle are provided elsewhere.(3, 6-8) In 
brief, a panel of clinicians (operating room nurses, anaesthetists and surgeons) and researchers 
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decided upon the central elements from the National Institute for Health and Clinical Excellence 
(NICE) guideline on the management of hypothermia during surgery using the electronic Guideline 
Implementability Appraisal (eGLIA) tool.(9) The central elements selected by the panel for the 
bundle were: 1) assessing risk for hypothermia and the complications associated with hypothermia 
during surgery; 2) Recording temperature at each phase of the perioperative journey (before, during 
and after surgery); and 3) Applying active warming with a forced air warming device intraoperatively 
to patients at-risk of hypothermia (using pre-determined criteria) or the complications of 
hypothermia, and at any time hypothermia was identified (defined as a temperature below 36°C). To 
implement the bundle, a collaborative model for implementation research based on the Institute of 
Healthcare Improvement’s Breakthrough Series Model(10) and the John’s Hopkins Translating 
Research into Practice model(11) was used. The model involved formation of a core team at each 
site who lead the implementation by: 1) accessing email and phone support from the research team 
when required; 2) attending workshops to learn about methods to utilise for local implementation; 
3) using a structured local barrier identification and mitigation tool(12); 4) using Plan-Do-Study-Act 
cycles (which were taught at the workshops). Implementation of bundle elements in practice (i.e. 
assessing risk, measuring temperature and initiating active warming) was a multi-disciplinary 
responsibility, but heavily reliant on nursing. As such, the core teams leading implementation at 
each site were primarily comprised of nursing staff from the clinical areas and those in 
managerial/executive roles. The effects of the bundle were evaluated using a multi-site pre and 
post-implementation design.(7) The primary finding of this study was that implementing the bundle 
into practice resulted in increased use of active warming (difference 14.3%; 95% CI= 5.5% to 23.2%).  
Despite the improvement in adherence to this important guideline recommendation, it is unknown 
whether the extra costs required for implementation were good value. It has recently been 
highlighted that is it vital to conduct robust economic evaluations of strategies used to improve 
uptake of evidence into practice.(13) This is because the efforts required for implementation exerts 
an impact on costs and can be complex and time-consuming for clinicians. The changes in costs 
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mainly arise from the resources needed for the implementation strategy and also due to the 
changes in service delivery costs in response to the implementation.(13) As such, this study aimed to 
determine if the strategy used to implement the thermal care bundle was cost-effective. 
 
Methods 
Research design 
A cost-effectiveness analysis was undertaken from the perspective of the Australian health care 
system funder. A probabilistic model was used for the primary analysis with model uncertainty 
quantified by drawing 1000 Monte-Carlo samples from probability distributions specified for model 
parameters.(14) Beta distributions were used for probabilities and utilities, gamma distributions 
were used for costs and lognormal distributions for relative risks. It was assumed that the 
parameters in the model were not correlated. Health benefits were measured using quality-adjusted 
life years (QALY) gained. Quality-adjusted life years represent both the additional duration and 
quality of life gained from an intervention. Quality of life is incorporated into the quality-adjusted life 
year measure by calculating utility scores, which provide a single index to describe health states 
ranging from 0 (worst health state) to 1 (perfect health). To illustrate, a person living for 10 years 
with a quality of life utility score of 0.8 is equivalent to 8 quality-adjusted life years. As such, the 
particular type of cost-effectiveness analysis we performed could be described as a ‘cost-utility’ 
analysis. Net monetary benefit was calculated by multiplying the health benefits associated with an 
intervention by the willingness-to-pay threshold minus the cost.(15) We tested a range of values for 
willingness to pay per quality-adjusted life year thresholds and plotted results for expected 
incremental benefits with 95% credible intervals as well as on a cost-effectiveness acceptability 
curve. All analyses were conducted in the statistical program R (16). The R code and calculations can 
be accessed via https://doi.org/10.6084/m9.figshare.6934325.v2 .  
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Ethics approval for this modelling study was not sought because we used previously published 
material as input for the model. The evaluation study was obtained from the site institutional 
Human Research Ethics Committee (LNR/14/SVH/403).   
 
The decision model 
The clinical problem is summarised in the decision tree presented in Figure 1. The decision tree 
displays the clinical outcomes of a hypothetical cohorts of surgical patients undergoing surgery at 
tertiary care hospitals undertaking between 5,000 and 40,000 surgeries per year, which either 
implemented or did not implement the thermal care bundle. The primary assumption for this cost-
effectiveness analysis was that patients included in the model would develop complications, 
including surgical site infection, bleeding and morbid cardiac events, at the same rate as those 
included in the active warming and standard care arms from previous randomised controlled trials. 
The rates of active warming use for the model were taken from the pre (38%) and post (53%) 
thermal care bundle implementation periods from our previous study.(7) The following explanation 
is provided to illustrate how these estimates of the effectiveness of the bundle in increasing the 
number of patients who receive active warming were translated to the cost-effectiveness model. On 
average in the model, 53% of patients undergoing surgery at a hospital who implemented the 
thermal care bundle would receive active warming and then develop surgical complications at the 
same rate as those who were randomised to receive active warming in previous randomised 
controlled trials. The remaining 47% of patients who would not have received active warming 
despite implementation of the thermal care bundle were modelled to develop surgical complications 
at the same rate as patients randomised to standard care (i.e. no active warming) arms in the prior 
randomised controlled trials. In contrast, 38% of patients undergoing surgery at a hospital in our 
model that did not implement the thermal care bundle would receive active warming and then 
develop surgical complications at the same rate as those who received active warming in the prior 
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randomised controlled trials. The remaining 62% of patients who would not have received active 
warming would be modelled to develop surgical complications at the same rate as patients 
randomised to the standard care (i.e. no active warming) arms of the prior randomised controlled 
trials. We did not include the potential risk for death arising from the more severe surgical 
complications such as deep surgical site infection and perioperative myocardial infarction in the 
model.  
 
Parameters for use in the model 
As our evaluation of the thermal care bundle(7) was not powered for cost-effectiveness, quality of 
life and costs associated with hypothermia-associated complications were derived from literature 
and then modelled using this information (2, 17). Table 1 presents the parameters and distributions 
for the probabilistic model.  
Probabilities 
The probabilities for the effect of active warming on surgical site infections after minor and major 
surgery were taken from two separate trials. For minor surgery, we used the estimate from a trial 
that randomised 421 patients having clean, minor surgery to no warming, pre-operative local 
warming (radiant heat over the surgical site) or pre-operative forced air warming (1). Fewer surgical 
site infections occurred in the warming group (8/139 versus 19/138; RR=0.42, 95% CI= 0.19 to 
0.92)(18). For major surgery, we used the estimate from a trial that randomised 200 patients 
undergoing colorectal surgery to receive passive insulation or intra-operative forced air 
warming.(19) There were fewer infections in the forced air warming group (18% versus 6%). 
However, classifications for superficial or deep infections were not reported in either of the trials. 
For this reason, we conservatively assumed that all infections after minor surgery were superficial, 
and used results from a more recent study, which identified that 30% of infections after midline 
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abdominal laparotomy were deep, for our estimate for major surgery.(20) The probabilities for the 
effect of active warming on cardiac events was taken from a randomised controlled trial of forced air 
warming for patients at high-risk of cardiovascular complications undergoing major surgery.(21) 
Active warming reduced the risk of a morbid cardiac event (defined as a cardiac arrest, unstable 
angina, or myocardial infarction.(22) High risk was defined in the trial as having previous coronary 
artery disease, undergoing a procedure to treat peripheral vascular disease or 2 or more risk factors 
including, diabetes, hypertension, smoking, hyperlipidaemia or age over 65.(21) Due to the strict 
inclusion criteria for this study, in our probabilistic model we assumed that 20% of patients 
undergoing major surgery would meet this criteria and hence be classified as ‘at-risk’ of cardiac 
events. The probabilities for both baseline rate and the effect of active warming on blood 
transfusion requirement were drawn from the Cochrane review.(18)   
 
Costs 
Costs were calculated in Australian dollars ($AUD) in 2018. There was no discounting of costs 
because the model horizon was only one year. Costs associated with implementation of the thermal 
care bundle were calculated using estimations of resource consumption of staff time and thermal 
care bundle (Supplementary File Table 1).   
 
Although there are many different active warming interventions available and utilisation of 
particular devices differs between institutions, the thermal care bundle emphasised use of forced air 
warming. The cost of forced air warming was estimated to vary between $10-30. An additional cost 
for purchasing forced air warming units was not included because it was assumed that all surgical 
facilities would have these available.  
The distributions from a recent cost-effectiveness analysis that included costs for surgical site 
infection in the Australian context were used to inform our model.(23) These distributions were 
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based on the cost of treatment for a superficial surgical site infection (comprising a primary care 
practitioner visit, course of oral antibiotics and a pathology test) equating to $250(24) and the cost 
of treatment for deep surgical site infection (comprising hospitalisation, pathology tests, and 
intravenous antibiotics for 1-2 weeks) equating to $10,000.(25) The estimate for costs of a cardiac 
event were taken from a recent cost-effectiveness analysis.(26) The costs for a suspected myocardial 
infarction including emergency coronary angiography, transthoracic echocardiography and serial 
pathology tests and electrocardiograms were converted from UK currency to Australian dollars 
($20,000). The average price per unit of blood product was estimated to be $400. This figure was 
sourced from the Australian Red Cross (2017)(33). 
 
Utilities 
The distributions for utilities were mostly drawn from a recent cost-effectiveness analysis 
undertaken in the Australian health care context.(26) These distributions were based on a utility 
score of 0.9 where no surgical complications occurred(27) and a disutility of 0.2 and 0.4 for 
superficial and deep surgical site infection, respectively(28). Utilities were based on EuroQoL 5D 
scores with 0 representing death and 1 a state of perfect health. We assumed the disutility of 
superficial surgical site infection would be present for two weeks and the disutility of deep surgical 
site infection for one month. The utility score for patients who have sustained a perioperative 
cardiac event (0.84) was drawn from a different cost-effectiveness analysis.(29) We did not include a 
disutility for blood transfusion requirement for consistency with previous economic analyses.(2) 
 
Sensitivity analyses 
The impact of assumptions made about specific model parameters was explored separately using 
univariate sensitivity analysis. Minimum and maximum values for parameters were substituted one 
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at a time into separate models populated only by base-case values. Base-case values were the 
averages of all the parameters included in the full probabilistic model (Table 1). Results of sensitivity 
analyses were plotted in a tornado diagram of the difference between the base-case estimates of 
the incremental net benefit associated with implementing the thermal care bundle at a willingness 
to pay threshold of $25,000 per quality-adjusted life year. We used the incremental net benefit in a 
tornado diagram to avoid plotting negative incremental cost-effectiveness ratio values, which are 
meaningless.(30)   
 
Results 
On average, implementation of the thermal care bundle resulted in a $689,659 decrease in costs. 
There was some uncertainty surrounding this estimate with lower and upper 95% credible intervals 
spanning from a $379,826 increase in costs to $2,718,364 decrease in costs. Quality-adjusted life 
years were higher for the thermal care bundle across nearly all simulations (97% probability of 
higher number of quality-adjusted life years; mean difference was 54 more quality-adjusted life 
years; 95% credible intervals 0.4 less to 176 more quality-adjusted life years). The cost-effectiveness 
plane is presented in Figure 2. Implementation of the thermal care bundle resulted in a reduction in 
both costs and quality-adjusted life years in the majority of simulations (88.1%). This equated to an 
incremental cost-effectiveness ratio of $12747 saved per quality-adjusted life year gained. 
Supplementary file figure 1 shows the probability that implementing the thermal care bundle would 
be cost-effective and Supplementary file Figure 2 displays the incremental net benefit (with 95% 
credible intervals) across a range of willingness to pay thresholds. 
 
 
Sensitivity analyses 
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Univariate sensitivity analyses were undertaken to further explore parameter uncertainty. The 
tornado diagram in Figure 3 shows that cost-effectiveness estimates differed considerably from the 
base-case result when extreme minimum and maximum values were substituted into the model for 
several of the parameters. These parameters included the effect of implementing the thermal care 
bundle on use of active warming, the percentage of minor operations performed at a hospital, the 
number of surgeries performed per year, the cost of treating a deep surgical site infection, and the 
percentage of surgical site infections after major surgery that are classified as deep.  
 
DISCUSSION 
The aim of this study was to determine if the strategies used to implement a bundle of evidence-
based interventions for perioperative thermal care was cost-effective. Results from the probabilistic 
cost-effectiveness model indicate that it is highly likely (about 80%) implementing the thermal care 
bundle would generate cost-savings for the health care system and improve quality of life for 
patients undergoing surgery. Therefore, it would be good value for hospitals to allocate the extra 
resources required to implement the thermal care bundle.   
 
Univariate sensitivity analyses revealed that substituting in extreme minimum and maximum values 
for several of the parameters resulted in cost-effectiveness estimates that were considerably 
different from the base-case result. These analyses provide important insights into the 
generalisability of the model. For example, implementation of the thermal care bundle at hospitals 
that perform none or small amounts of major surgery is unlikely to be cost-effective. Also, the 
number of surgeries performed at a hospital is central to determining whether implementation will 
be cost-effective or not. This finding is important because hospitals that perform a lower number of 
surgeries would still need to undertake a similar amount of work to properly implement the bundle 
as a larger hospital and therefore require a similar amount of resources. As such, this would increase 
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the cost of implementation per patient, which our sensitivity analyses indicate would impact cost-
effectiveness estimates considerably. In contrast, it should be noted that increasing the cost of 
active warming per patient did not have a considerable impact on the expected net benefit of 
implementing the thermal care bundle. Consequently, hospitals that employ more expensive 
methods of active warming should still expect that implementing the thermal care bundle to 
increase the use of active warming would be a cost-effective strategy.  
Although we were able to estimate the cost-effectiveness of a decision to adopt implementation of 
the thermal care bundle across a range of values as per the standard approach, inputting values for 
parameters that are specific to a hospital into our model would be more informative for decision 
makers. To assist, we have developed an interactive webpage 
(https://sedationapps.shinyapps.io/thermalbundleCEA ), so that decision-makers can estimate the 
probability that implementing the thermal care bundle would be cost-effective at their hospital. On 
the webpage, decision-makers first input the number of surgical procedures performed per year, the 
proportion of procedures classified as minor, the specific amounts they are required to pay for active 
warming per patient, as well as their currency code to allow for conversion. In response, 
individualised output including a cost-effectiveness plane, incremental net benefit and probability of 
cost-effectiveness across a range of Willingness-To-Pay thresholds and estimates of the differences 
in costs and quality-adjusted life years between decisions to either adopt or not adopt the thermal 
care bundle is produced to assist their decision making.   
 
As with all probabilistic cost-effectiveness models that draw evidence from the literature as input, 
study quality should be considered. In this regard, it should be noted that the evidence for a 
reduction in risk of cardiac events was rated as low quality by the authors of a recent Cochrane 
review(18), due to concerns about imprecision considering that there was only one myocardial 
infarction event and no mortality observed in the one trial that reported on this outcome.(22)  
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Similarly, the Cochrane review rated the quality of evidence for the effect of active warming on 
surgical site infection as low quality, again due to concerns about imprecision.(18) The quality of 
evidence for the effect of active warming on the requirement for blood transfusion was rated as 
moderate quality due to concerns about risk of bias.(18) However, the quality of all warming 
intervention studies is said to be of low quality because the intervention is difficult or impossible to 
blind. Still it was noted by the Cochrane review authors that further studies were unlikely to exert a 
substantial change to the effect estimate. Therefore, despite there being only low to moderate 
quality evidence available about the effect of active warming on surgical complications, this was 
mostly driven by downgrading for imprecision. As such, by utilising a probabilistic cost-effectiveness 
model, the uncertainty arising from the inclusion of these imprecise estimates in the model has been 
quantified by drawing simulations from probability distributions.  
 
Results from this cost-effectiveness analysis should be considered applicable only to the 
demographic and setting of the evaluation study we conducted to estimate the success of the 
thermal care bundle on increasing use of active warming for patients at-risk of perioperative 
hypothermia.(7) Therefore, results of this cost-effectiveness analysis may not generalise to other 
populations where considerably more resources would be required to exert a similar impact on 
increasing use of active warming. For example, in some countries, such as China, it is rare for active 
warming to be utilised during surgery.(31) Likewise, there are some institutions where active 
warming is almost universally applied, so implementation of the thermal care bundle would not be a 
good investment in such circumstances.(32)  Finally, it should also be noted that our estimate of the 
effect of the thermal care bundle on increasing use of active warming was based on a non-
randomised, pre-test post-test comparison. More confidence in the effect of the bundle on use of 
application of active warming for patients at-risk of hypothermia could be drawn if the study was 
replicated using a randomised controlled trial design. It is likely that due to the nature of the 
intervention that a cluster approach to randomisation would be required for such an approach. 
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However, delaying implementation of the bundle to wait for more definitive evidence from a 
randomised controlled trial means the health system may be missing out on the cost-savings and 
health benefits projected by our model.   
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Contribution of the paper 
What is already known about the topic? 
 Clinical guidelines recommend that active warming should be used peri-operatively to 
prevent surgical complications that are associated with high costs and reduced quality of life 
such as surgical site infections and bleeding. 
 A multi-site pre-post implementation study showed that a Thermal Care Bundle, mostly led 
by nurses, increased adherence to clinical guideline recommendations, with active warming 
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being applied to 15% more patients at-risk of perioperative hypothermia in the post-
implementation phase. 
 
 
What this paper adds 
 It would be a good decision for hospitals with similar profiles to those included in our 
probabilistic cost-effectiveness model to allocate the extra resources required to implement 
the thermal care bundle as it is highly likely to result in reduced costs and improved quality 
of life. 
 We have developed an interactive webpage 
(https://sedationapps.shinyapps.io/thermalbundleCEA ), so that decision-makers can 
estimate the probability that implementing the thermal care bundle would be cost-effective 
at their hospital. 
 Delaying implementation of the bundle to wait for more definitive evidence from a 
randomised controlled trial means the health system may be missing out on the large 
amount of cost-savings and health benefits projected by our model.   
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Figure 1. Economic model structure 
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Figure 2. Cost-effectiveness plane 
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Figure 3. Tornado diagram for sensitivity analyses 
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Table 1. Cost-effectiveness model input parameters 
Parameter Average 
value 
Distribution Source 
Population  10000 Uniform (min=5000, 
max=40000) 
Estimated from 
number of surgeries 
performed at each 
site from prior 
study(7) 
Increase in active warming with 
implementation of the thermal 
care bundle 
1.38 Log-normal (0.32, 0.12) Duff et al., (2018)(7) 
Percentage of surgeries that are 
minor 
40% Beta (α=60, β=40) Estimate 
Baseline risk of superficial surgical 
site infection after minor surgery 
13% Beta (α=19, β=120) Melling et al., 
(2001)(1) 
Relative risk of superficial surgical 
site infection after minor surgery 
with active warming 
0.42 Log-normal (0.19-0.92) Melling et al., 
(2001)(1) 
Risk of surgical site infection after 
major surgery without active 
warming 
19% Beta (α=18, β=78) Kurz et al., (1996)(19) 
Relative risk of surgical site 
infection after major surgery with 
active warming 
0.30 Log-normal (-1.17, 
0.15) 
Kurz et al., (1996)(19) 
Percentage of infections after 
major surgery that are deep 
30% Beta (α=47, β=109) Diener et al., 
(2014)(20) 
Percentage of major surgery 
patients at high risk of cardiac 
events 
20% Beta (α=20, β=80) Frank et al., 
(1997)(22) 
Risk of cardiac event after major 
surgery in high-risk patients 
without active warming 
7% Beta (α=10, β=148) Frank et al., 
(1997)(22) 
Risk of cardiac event after major 
surgery in high-risk patients with 
active warming 
1.4% Beta (α=2, β=140) Frank et al., 
(1997)(22) 
Baseline risk of blood transfusion 
during major surgery 
0.17 Beta (α=52, β=304) Madrid et al., 
(2016)(18) 
Relative risk of blood transfusion 
during major surgery 
0.79 Log-normal (-0.23, 
0.19) 
Madrid et al., 
(2016)(18) 
Cost of treating superficial surgical 
site infection  
$250 Gamma (α =4, β =0.02) Graves et al., 
(2006)(24) 
Cost of treating deep surgical site 
infection 
$10000 Gamma (α =4, β 
=0.0004) 
AR-DRGs (AIHW) 
Cost of treating a post-operative 
cardiac event 
$20000 Gamma (α =80, β 
=0.004) 
Stokes et al., 
(2016)(26) 
Cost of a blood transfusion $400 Gamma (α =2000, β =5) Australian Red Cross 
(2017) (33) 
Cost of active warming $20 Gamma (α =100, β =5) Market price 
Cost of implementing the thermal 
care bundle 
$10630 
per 
 Fixed cost calculated 
from prior study(7) 
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hospital 
for one 
year 
Utility with no surgical 
complications 
0.91 Beta (α=185, β=18) Clemens et al., 
(2014)(27) 
Disutility of superficial surgical site 
infection 
0.2 Beta (α=8, β=41) Lipsky et al., 
(2012)(28) 
Disutility of deep surgical site 
infection 
0.4 Beta (α =16, β =40) Lipsky et al., 
(2012)(28) 
Disutility of cardiac event 0.16 Beta (α =0.835, β 
=0.165) 
Rao et al., (2008)(29) 
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